Search
CO-TANZAAR 50 MG / 12.5 MG, Comprimé pelliculé
Details
| --- | Description |
|---|---|
| Pack | Boite de 14 |
| Strength (Dosage) | 50 MG | 12.5 MG |
| Laboratory | AFRIC-PHAR |
| Ingredients | Losartan | Hydrochlorothiazide |
| Therapeutic class | Association de 2 antihypertenseurs : Antagoniste des récepteurs de l'angiotensine II et diurétique |
| ATC code | C09DA01 |
| PPH | $3.79 |
| PPV | $6.06 |
| Refundable | Yes |
| Refund base | $6.06 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Medication |
| Uses | Traitement de l’hypertension artérielle essentielle chez les patients dont la pression artérielle n’est pas suffisamment contrôlée par le losartan ou l’hydrochlorothiazide en monothérapie. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications with one or more of the ingredients above
Medications under one or more of the therapeutic classes above
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem